Elizabeth E. Evans - 20 Mar 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Chief Operating Officer
Signature
/s/ Maurice Zauderer, Attorney-in-Fact for Elizabeth E. Evans
Issuer symbol
VCNX
Transactions as of
20 Mar 2024
Transactions value $
$0
Form type
4
Filing time
22 Mar 2024, 16:33:10 UTC
Previous filing
03 Apr 2023
Next filing
14 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 46 20 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +1.34K $0.00 1.34K 20 Mar 2024 Common Stock 1.34K $8.32 Direct F6
holding VCNX Stock Option (Right to Buy) 45 20 Mar 2024 Common Stock 45 $1,491.00 Direct F1
holding VCNX Stock Option (Right to Buy) 40 20 Mar 2024 Common Stock 40 $1,491.00 Direct F1
holding VCNX Stock Option (Right to Buy) 59 20 Mar 2024 Common Stock 59 $819.00 Direct F1
holding VCNX Stock Option (Right to Buy) 47 20 Mar 2024 Common Stock 47 $802.20 Direct F2
holding VCNX Stock Option (Right to Buy) 38 20 Mar 2024 Common Stock 38 $615.30 Direct F3
holding VCNX Stock Option (Right to Buy) 95 20 Mar 2024 Common Stock 95 $270.90 Direct F4
holding VCNX Stock Option (Right to Buy) 190 20 Mar 2024 Common Stock 190 $83.90 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully exercisable as of the date of this report.
F2 This option vests one-fourth on each of the first four anniversaries of the April 3, 2020 grant date, except as otherwise provided in the award notice.
F3 This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice.
F4 This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice.
F5 This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice.
F6 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 20, 2024 grant date.

Remarks:

All figures in this Form 4 reflect the Issuer's 1-for-15 reverse stock split effected on September 25, 2023 and 1-for-14 reverse stock split effected on February 19, 2024.